Nemaura Medical's latest marketcap:
As of 07/30/2025, Nemaura Medical's market capitalization has reached $8,070. According to our data, Nemaura Medical is the 49562th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 8,070 |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -10,650,933 |
| Shares Out | 40.35 M |
| EPS (ttm) | -0.38 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 11/13/2025 |
Nemaura Medical's yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/30/2025 | $8,070 | 100% | 49562 |
| 12/31/2024 | $4,035 | -99.94% | 48387 |
| 12/29/2023 | $6.33 M | -84.71% | 46712 |
| 12/30/2022 | $41.39 M | -61.06% | 44970 |
| 12/31/2021 | $106.28 M | 23.06% | 42936 |
| 12/31/2020 | $86.37 M | 18.59% | 39704 |
| 12/31/2019 | $72.83 M | -61.05% | 36993 |
| 12/31/2018 | $186.96 M | -45.83% | 35595 |
| 12/29/2017 | $345.15 M | 12.24% | 34064 |
| 12/27/2016 | $307.5 M | -12.14% | 32030 |
Company Profile
About Nemaura Medical Inc.
Nemaura Medical Inc. is a pioneering medical technology company specializing in innovative glucose monitoring solutions. Headquartered in New York, New York, the company was established in 2009 with a mission to revolutionize diabetes management.
Key Products & Services
- sugarBEAT® – A non-invasive, continuous glucose monitoring (CGM) device designed for individuals with Type I and Type II diabetes, as well as pre-diabetic screening.
- proBEAT™ – A wellness guidance system that provides real-time prompts and educational insights on factors influencing blood sugar levels, empowering users to make informed health decisions.
Commitment to Diabetes Care
Beyond its cutting-edge devices, Nemaura Medical Inc. actively engages in diabetes prevention and reversal programs, supporting patients through comprehensive, data-driven health strategies.
Frequently Asked Questions
-
What is Nemaura Medical's (OTC-NMRD) current market cap?As of 07/30/2025, Nemaura Medical (including the parent company, if applicable) has an estimated market capitalization of $8,070 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Nemaura Medical (OTC-NMRD) rank globally by market cap?Nemaura Medical global market capitalization ranking is approximately 49562 as of 07/30/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.